McMillan A - Search Results

1

FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study.

Mikhaeel NG, Cunningham D, Counsell N, McMillan A, Radford JA, Ardeshna KM, Lawrie A, Smith P, Clifton-Hadley L, O'Doherty MJ, Barrington SF. Mikhaeel NG, et al. Among authors: mcmillan a. Br J Haematol. 2021 Feb;192(3):504-513. doi: 10.1111/bjh.16875. Epub 2020 Jul 4. Br J Haematol. 2021. PMID: 32621535 Free article. Clinical Trial.

2

Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI).

Yung L, Cunningham D, Hancock B, Smith P, Maclennan K, Linch D, McMillan A. Yung L, et al. Among authors: mcmillan a. Br J Cancer. 2004 Aug 16;91(4):695-8. doi: 10.1038/sj.bjc.6602031. Br J Cancer. 2004. PMID: 15280929 Free PMC article. Clinical Trial.

3

Central nervous system-directed preventative therapy in adults with lymphoma.

McMillan A. McMillan A. Br J Haematol. 2005 Oct;131(1):13-21. doi: 10.1111/j.1365-2141.2005.05703.x. Br J Haematol. 2005. PMID: 16173958 Free article. Review.

4

Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.

Ingram W, Devereux S, Das-Gupta EP, Russell NH, Haynes AP, Byrne JL, Shaw BE, McMillan A, Gonzalez J, Ho A, Mufti GJ, Pagliuca A. Ingram W, et al. Among authors: mcmillan a. Br J Haematol. 2008 Apr;141(2):235-43. doi: 10.1111/j.1365-2141.2008.07067.x. Epub 2008 Mar 3. Br J Haematol. 2008. PMID: 18318762 Free article.

5

IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.

Fox CP, McMillan AK, Bishton MJ, Haynes AP, Russell NH. Fox CP, et al. Among authors: mcmillan ak. Br J Haematol. 2008 Apr;141(2):244-8. doi: 10.1111/j.1365-2141.2008.07068.x. Br J Haematol. 2008. PMID: 18353164 Free article.

6

Facilities for the treatment of adults with haematological malignancies--'Levels of Care': BCSH Haemato-Oncology Task Force 2009.

Matthey F, Parker A, Rule SA, Wimperis JZ, Ardeshna KM, Bird JM, Cullis J, Lyttelton MP, McMillan A, Jackson GH. Matthey F, et al. Among authors: mcmillan a. Hematology. 2010 Apr;15(2):63-9. doi: 10.1179/102453309X12583347113492. Hematology. 2010. PMID: 20423565 No abstract available.

7

Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).

Dearden CE, Johnson R, Pettengell R, Devereux S, Cwynarski K, Whittaker S, McMillan A; British Committee for Standards in Haematology. Dearden CE, et al. Among authors: mcmillan a. Br J Haematol. 2011 May;153(4):451-85. doi: 10.1111/j.1365-2141.2011.08651.x. Epub 2011 Apr 11. Br J Haematol. 2011. PMID: 21480860 Free article. Review.

8

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.

Sive JI, Buck G, Fielding A, Lazarus HM, Litzow MR, Luger S, Marks DI, McMillan A, Moorman AV, Richards SM, Rowe JM, Tallman MS, Goldstone AH. Sive JI, et al. Among authors: mcmillan a. Br J Haematol. 2012 May;157(4):463-71. doi: 10.1111/j.1365-2141.2012.09095.x. Epub 2012 Mar 13. Br J Haematol. 2012. PMID: 22409379 Free PMC article. Clinical Trial.

9

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.

Cunningham D, Hawkes EA, Jack A, Qian W, Smith P, Mouncey P, Pocock C, Ardeshna KM, Radford JA, McMillan A, Davies J, Turner D, Kruger A, Johnson P, Gambell J, Linch D. Cunningham D, et al. Among authors: mcmillan a. Lancet. 2013 May 25;381(9880):1817-26. doi: 10.1016/S0140-6736(13)60313-X. Epub 2013 Apr 22. Lancet. 2013. PMID: 23615461 Free article. Clinical Trial.

10

Guideline on the prevention of secondary central nervous system lymphoma: British Committee for Standards in Haematology.

McMillan A, Ardeshna KM, Cwynarski K, Lyttelton M, McKay P, Montoto S; British Committee for Standards in Haematology. McMillan A, et al. Br J Haematol. 2013 Oct;163(2):168-81. doi: 10.1111/bjh.12509. Epub 2013 Aug 27. Br J Haematol. 2013. PMID: 24033102 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

746 results

Search Page